ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Articles tagged "Plasmapheresis"

  • 2017 American Transplant Congress

    The Inhibitory Effect of Plasma on T Cell Activation: Possible Role of Plasma Exchange in Anti Rejection Therapy.

    A. Assounga,1,2 S. Omarjee.1

    1Dept Nephrology, University of KwaZulu-Natal, Durban, South Africa; 2Inkosi Albert Luthuli Central Hospital, Durban, South Africa

    Reduction of lymphocyte proliferation by human plasma has been previously reported. Reduced activation of lymphocytes of patients on immunosuppressive drugs is well documented.Aim: To compare…
  • 2017 American Transplant Congress

    Renal Transplant Outcomes in Primary FSGS Compared with Other Recipients: A National Review of the Irish Transplant Registry.

    S. Cormican,1 C. Kennedy,1,2 P. O'Kelly,1 B. Doyle,3 A. Dorman,3 P. Conlon.1,2

    1Nephrology, Beaumont Hospital, Dublin, Ireland; 2Medicine, Royal College of Surgeons, Dublin, Ireland; 3Pathology, Beaumont Hospital, Dublin, Ireland

    Primary focal segmental glomerular sclerosis (p-FSGS) raises specific peri-transplant concerns, one of which is disease recurrence (r-FSGS). We aimed to compare transplant outcomes in patients…
  • 2017 American Transplant Congress

    Pre-Operative Desensitization for Live Donor Liver Transplantation with Strong Donor-Specific Antibodies.

    M. Fujiki,1 K. Hashimoto,1 A. Zhang,2 F. Aucejo,1 C. Quintini,1 T. Diago,1 B. Eghtesad,1 C. Miller.1

    1General Surgery, Cleveland Clinic, Cleveland, OH; 2Allogen Laboratories, Cleveland Clinic, Cleveland, OH

    Background: Presence of strong donor-specific antibodies (DSA) (MFI>4000) likely results in uncomplicated short-term outcome in whole liver transplants due to absorption of DSA by the…
  • 2017 American Transplant Congress

    Anti-CD25mAb Sparing Immunosuppressive Regimen Suppressed Recurrence of Post-Transplant Focal Segmental Glomerular Sclerosis- A Single Center Experience.

    H. Harada, Y. Wada, N. Fukuzawa.

    Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan

    INTRODUCTION: The rate of recurrence of primary focal segmental glomerular sclerosis (FSGS) is problematic, because it often results in very early serious urinary protein secretion…
  • 2016 American Transplant Congress

    Factors Associated with Response to Plasmapheresis in Patients with Recurrent FSGS.

    J. Shoji,1 V. Tatapudi,2 Z. Laszik,1 A. Jones,3 J. Wolf,4 D. Adey,1 F. Vincenti.1

    1Department of Medicine, Division of Nephrology, University of California-San Francisco, California, CA; 2Department of Medicine, Division of Nephrology, New York University, New York, NY; 3Department of Sociology, George Washington University, Washington, DC; 4Transplant Surgery, Piedmont Transplant Institute, Atlanta, GA.

    Background:Idiopathic focal segmental glomerulosclerosis (FSGS) is one of the primary glomerular diseases that commonly recurs in renal allograft and is known to be associated with…
  • 2016 American Transplant Congress

    Donor Specif Antibody (DSA) Kinetics in Patients with Antibody Mediated Rejection (AMR) Treated with Plasmapheresis and Bortezomib.

    L. Requião-Moura,1 M. Afonso,2 A. Sakashita,3 M. Silva,1 A. Matos,1 A. Pacheco-Silva.1

    1Kidney Transplant, Hospital Israelita Albert Einstein, São Paulo, Brazil; 2Histocompatibility Laboratory, Hospital Israelita Albert Einstein, São Paulo, Brazil; 3Blood Bank, Hospital Israelita Albert Einstein, São Paulo, Brazil.

    Backgroud: The best choice to treat AMR is not supported by several evidences, and recently the interest in drugs as Bortezomib has improved. Aim: Evaluted…
  • 2016 American Transplant Congress

    Postoperative Rebound of Anti-Blood Type Antibodies and Antibody-Mediated Rejection After ABO-Incompatible Living Related Kidney Transplantation – Is Prophylactic Treatment Necessary?

    H. Ishida, T. Kondo, T. Shimizu, T. Nozaki, K. Tanabe.

    Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan.

    PURPOSE: The role of postoperative anti-ABO titers in acute rejection under our current immunosuppressive regimen remains unclear. Some institutions recommend postoperative therapeutic plasma exchange to…
  • 2016 American Transplant Congress

    Early Posttransplant Complications Following Abo-Incompatible Kidney Transplantation.

    L. Rostaing,1,2,3 A. Allal,1 H. Naciri Benami,1 Z. Abdulrahman,1 L. Esposito,1 F. Sallusto,1 N. Doumerc,1 X. Game,1 B. Debiol,1 N. Congy,1 N. Kamar.1,3,4

    1Néphrologie et Transplantation d'Organes, CHU Rangueil, Toulouse, France; 2INSERM U 563, CHU Purpan, Toulouse, France; 3Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier, Toulouse, France; 4INSERM U1043 CNRS UMR 5282, CHU Purpan, Toulouse, France.

    Introduction: Many studies or registries particularly in Japan, but also in Western Europe, have shown that long-term results from ABO-incompatible (ABOi) living-kidney transplantation are as…
  • 2016 American Transplant Congress

    A2 Kidneys into B Recipients: Is Postoperative Anti-A1 Titer Monitoring Useful?

    A. DeMers, R. Forbes, D. Moore, K. Smith, D. Shaffer.

    Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, TN.

    Background: Since the introduction of the new Kidney Allocation System in December 2014, our center implemented a protocol for transplanting A2 kidneys into B recipients…
  • 2016 American Transplant Congress

    Utilization of Plasmapheresis and High Dose of Immunoglobulins in the Treatment of the High Level of De Novo Donor Specific Antibodies for the Successful Islet Allotransplantation.

    J. Solomina,1 Z. Tekin,1 S. Matosz,1 K. Golab,1 C. Thomas,2 J. Golebiewska,3 S. Ramachandran,1 L. Schenck,1 W. Chon,1 M. Tibudan,1 N. Marek-Trzonkowska,4 J. Millis,1 P. Witkowski.1

    1Surgery, University of Chicago, Chicago, IL; 2Medicine, University of Chicago, Chicago, IL; 3Internal Medicine, Medical University of Gdansk, Gdansk, Poland; 4Family Medicine, Medical University of Gdansk, Gdansk, Poland.

    Background.Development of donor specific antibodies (DSA) after islet transplantation has been a poor prognostic factor for graft survival, while no intervention is implemented. Here, we…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Home
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

wiley-new-logo

This site uses cookies: Find out more.